IFG Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,292
| Closed | -$3.04M | – | 351 |
|
|
2025
Q4 | $3.04M | Buy |
9,292
+3
| +0% | +$952 | 0.13% | 190 |
|
|
2025
Q3 | $2.62M | Buy |
9,289
+106
| +1% | +$30.7K | 0.12% | 199 |
|
|
2025
Q2 | $2.56M | Buy |
9,183
+40
| +0.4% | +$11.3K | 0.13% | 193 |
|
|
2025
Q1 | $2.85M | Sell |
9,143
-336
| -4% | -$99.2K | 0.16% | 163 |
|
|
2024
Q4 | $2.47M | Buy |
9,479
+35
| +0.4% | +$10.4K | 0.14% | 178 |
|
|
2024
Q3 | $3.04M | Sell |
9,444
-104
| -1% | -$34K | 0.19% | 144 |
|
|
2024
Q2 | $2.98M | Sell |
9,548
-152
| -2% | -$44.7K | 0.19% | 133 |
|
|
2024
Q1 | $2.76M | Buy |
9,700
+56
| +0.6% | +$16.4K | 0.21% | 139 |
|
|
2023
Q4 | $2.78M | Sell |
9,644
-142
| -1% | -$38.7K | 0.2% | 133 |
|
|
2023
Q3 | $2.63M | Sell |
9,786
-83
| -0.8% | -$20.7K | 0.22% | 120 |
|
|
2023
Q2 | $2.19M | Buy |
9,869
+332
| +3% | +$77K | 0.19% | 150 |
|
|
2023
Q1 | $2.31M | Buy |
9,537
+1,533
| +19% | +$376K | 0.22% | 114 |
|
|
2022
Q4 | $2.1M | Sell |
8,004
-164
| -2% | -$44K | 0.21% | 110 |
|
|
2022
Q3 | $1.84M | Buy |
8,168
+1,184
| +17% | +$287K | 0.17% | 130 |
|
|
2022
Q2 | $1.7M | Sell |
6,984
-7,311
| -51% | -$1.79M | 0.18% | 126 |
|
|
2022
Q1 | $3.46M | Buy |
14,295
+3,356
| +31% | +$771K | 0.35% | 62 |
|
|
2021
Q4 | $2.46M | Buy |
10,939
+136
| +1% | +$28.7K | 0.24% | 99 |
|
|
2021
Q3 | $2.3M | Buy |
10,803
+179
| +2% | +$41.2K | 0.25% | 101 |
|
|
2021
Q2 | $2.59M | Sell |
10,624
-2,613
| -20% | -$643K | 0.29% | 78 |
|
|
2021
Q1 | $3.29M | Buy |
13,237
+410
| +3% | +$97.8K | 0.41% | 53 |
|
|
2020
Q4 | $2.95M | Buy |
12,827
+5,108
| +66% | +$1.18M | 0.41% | 58 |
|
|
2020
Q3 | $1.96M | Buy |
7,719
+188
| +2% | +$46.6K | 0.32% | 69 |
|
|
2020
Q2 | $1.78M | Buy |
7,531
+18
| +0.2% | +$4.11K | 0.32% | 74 |
|
|
2020
Q1 | $1.52M | Sell |
7,513
-59
| -0.8% | -$12.9K | 0.34% | 74 |
|
|
2019
Q4 | $1.82M | Sell |
7,572
-475
| -6% | -$105K | 0.33% | 85 |
|
|
2019
Q3 | $1.56M | Buy |
8,047
+265
| +3% | +$50.9K | 0.3% | 93 |
|
|
2019
Q2 | $1.43M | Sell |
7,782
-90
| -1% | -$16.1K | 0.25% | 85 |
|
|
2019
Q1 | $1.5M | Sell |
7,872
-51
| -0.6% | -$9.74K | 0.29% | 75 |
|
|
2018
Q4 | $1.54M | Sell |
7,923
-452
| -5% | -$88.2K | 0.36% | 66 |
|
|
2018
Q3 | $1.74M | Sell |
8,375
-1,036
| -11% | -$204K | 0.33% | 71 |
|
|
2018
Q2 | $1.74M | Sell |
9,411
-559
| -6% | -$98.9K | 0.36% | 62 |
|
|
2018
Q1 | $1.7M | Buy |
9,970
+451
| +5% | +$82.8K | 0.38% | 59 |
|
|
2017
Q4 | $1.66M | Buy |
+9,519
| New | +$1.68M | 0.37% | 62 |
|
Other funds holding AMGN
VCM
VPM
IFG Advisory's AMGN Position: Q1 2026 in Review
IFG Advisory sold out of Amgen (AMGN) in Q1 2026, closing a stake of 9,292 shares — an estimated $3.04M sold.
IFG Advisory first reported a position in AMGN in Q4 2017 and held it in 33 quarters. The position peaked at $3.46M in Q1 2022. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- IFG Advisory reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- IFG Advisory sold 9,292 Amgen shares in Q1 2026, an estimated $3.04M.
- IFG Advisory first reported a position in Amgen in Q4 2017 and held it in 33 quarters.
- IFG Advisory's Amgen position peaked at $3.46M in Q1 2022.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.